We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

Since 2008, our preferred measure of health-related quality of life in adults has been EQ‑5D. For most of that time, there has been only 1 version of the descriptive system, EQ‑5D‑3L. In this version, ...

We have updated this service so that members of the same organisation can now collaborate on a joint online response.

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

All NICE products on varicose veins. Includes any guidance and quality standards.

our 5 overarching NICE-wide areas of focus (with specific objectives for each) improve the diversity of our workforce create a consciously inclusive work culture build a community of inclusive leaders ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

We invite relevant stakeholders to take part in the appraisal. All non-company consultees have 8 weeks to submit a statement on the potential clinical and cost effectiveness of a treatment. We ask the ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

Elranatamab for treating relapsed and refractory multiple myeloma after 3 or more treatments TA1023 11 December 2024 11 December 2024 ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.